Results 31 to 40 of about 22,412 (196)
Heparin-induced thrombocytopenia type II is a rare but devastating complication of heparin exposure. We review a case of a 66-year-old female who underwent aortic valve surgery requiring venoarterial extracorporeal membranous oxygenation (ECMO) support ...
Allan M Klompas +3 more
doaj +1 more source
Complement activation as a biomarker for platelet-activating antibodies in heparin-induced thrombocytopenia. [PDF]
Myoung SS +9 more
europepmc +3 more sources
We report a case of a 62‐year‐old man who developed cerebral venous sinus thrombosis with subarachnoid hemorrhage and concomitant thrombocytopenia, which occurred 13 days after ChAdOx1 nCov‐19 injection.
Alice Bérezné +13 more
doaj +1 more source
Heparin-induced thrombocytopenia is a well-known, life-threatening complication that occurs in 5% of patients exposed to heparin. It causes thrombocytopenia in roughly 85% to 90% of affected individuals, with expected recovery in approximately 4 to 10 ...
Devon S. McKenzie MD +3 more
doaj +1 more source
Background: COVID-19 disease is accompanied by derangement of coagulation with a risk of fatal thromboembolic formation. COVID-19 patients are among those indicative for heparin treatment.
Louisa Fadjri Kusuma Wardhani +3 more
doaj +1 more source
Heparin-induced thrombocytopenia: an update
Heparin-induced thrombocytopenia (HIT) is the most important and most frequent drug-induced, immune-mediated type of thrombocytopenia. It is associated with significant morbidity and mortality if unrecognized.
Franchini Massimo
doaj +1 more source
Heparin-induced thrombocytopenia following coronary artery bypass grafting: a diagnostic dilemma [PDF]
The diagnosis of heparin-induced thrombocytopenia (HIT) is a challenge in post-cardiac surgery patients because of the high incidence of non-immune thrombocytopenia and heparin–platelet factor 4 antibodies in these groups.
Raju Khanal +2 more
doaj +1 more source
Delayed‐onset heparin‐induced thrombocytopenia complicated with saddle embolus
Delayed‐onset heparin‐induced thrombocytopenia is a rare complication of heparin in which thrombocytopenia and thrombosis occur several days after heparin cessation.
Faezeh Sadat Naji +4 more
doaj +1 more source
Unlike deceased‐donor liver transplantation, living‐donor liver transplantation (LDLT) for Budd‐Chiari Syndrome (BCS) presents distinctive challenges in hepatic venous (HV)‐outflow reconstruction because diseased HV–inferior vena cava (IVC) cannot be entirely replaced with healthy donor vessels.
Koichiro Hata +4 more
wiley +1 more source
THE HEPARIN INDUCED THROMBOCYTOPENIA IN CARDIAC SURGERY PATIENTS
Objective: Combination of ‘4Ts’ clinical scoring system and Particle gel immunoassay to determine the frequency of heparin-induced thrombocytopenia during heparin treatment in cardiac surgery patients. Study Design: Prospective observational study.
Shakila Khadim +5 more
doaj +1 more source

